Science
B.C. particle accelerator scores triumph with deal to produce ‘rarest drug on earth’ – q107.com
UBC’s TRIUMF facility is gearing up to produce actinium-225, a rare radioisotope that early research shows could have a powerful effect fighting cancer.
A team at the Canada’s particle accelerator facility at the University of British Columbia is celebrating a major triumph, inking a deal to produce a rare cancer drug that previously relied on nuclear waste.
The TRIUMF project has formed a partnership with Ontario-based Fusion Pharmaceuticals to upgrade its facility to produce actinium-225, nicknamed “the rarest drug on Earth.”
Read more: BWXT Peterborough touts ‘tremendous progress’ in medical isotope production at Darlington nuclear station
That…
-
Noosa News24 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General23 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General20 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General16 hours agoRegional house price growth outstrips capital cities